SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-011915
Filing Date
2023-05-01
Accepted
2023-05-01 16:34:59
Documents
14
Period of Report
2023-04-30
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20230425d_8k.htm   iXBRL 8-K 30937
2 EXHIBIT 3.1 ex_508441.htm EX-3.1 246098
  Complete submission text file 0001437749-23-011915.txt   469315

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20230430.xsd EX-101.SCH 4059
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20230430_def.xml EX-101.DEF 13926
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20230430_lab.xml EX-101.LAB 18274
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20230430_pre.xml EX-101.PRE 13948
8 EXTRACTED XBRL INSTANCE DOCUMENT bcda20230425d_8k_htm.xml XML 4425
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 23874314
SIC: 2836 Biological Products, (No Diagnostic Substances)